Royalty Pharma Reports Second Quarter 2021 Results
Go back to Royalty Pharma Reports Second Quarter 2021 Results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 55.35 +1.78 (3.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.57 | 52 Week High | $3.48 | |||
| Open | $53.58 | 52 Week Low | $0.80 | |||
| Day High | $55.50 | P/E | N/A | |||
| Day Low | $53.31 | EPS | $-1.54 | |||
| Volume | 4,857,699 | |||||
